Search results

We have provided answers to some the frequently asked questions about the CORIS360® imaging technology.

His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of the Commonwealth of Australia and Her Excellency Mrs Linda Hurley visited ANSTO’s Innovation Centre nandin and several facilities including the OPAL multipurpose reactor this week for a tour after learning of the ANSTO-nandin win in the NASA SpaceApps COVID 19 Challenge.

Progress on tailorable nanoscale emulsion for a wide variety of applications including drug delivery

General manager ANSTO Communications and Stakeholder Engagement was one of the presenters at the IAEA W4NSEC workshop

Australian Centre for Neutron Scattering succcess at 2017 awards

Collaborators on the Magnetism project.

The Macromolecular and Microfocus Crystallography beamlines at the Australian Synchrotron (MX1 and MX2) are general purpose crystallography instruments for determining chemical and biological structures.

ANSTO welcomes the Federal Budget, which supports ongoing operations.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Specifications and User Manual

Neutron powder diffraction is particularly useful for materials with light elements in the presence of heavy ones and for magnetic materials such as superconductors, pharmaceuticals, aerospace alloys and much more.